STOCK TITAN

Leidos Security Enterprise Solutions and Analogic partner to form American joint venture and strengthen global security screening capabilities

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
partnership

Leidos (NYSE: LDOS) and Altaris formed a U.S.-based joint venture combining Leidos Security Enterprise Solutions and Analogic to strengthen global security screening. The new privately held company will operate under the Analogic brand, with Leidos retaining significant minority ownership.

Leidos will contribute ~1,500 employees and $625 million of projected 2026 revenue. The deal targets faster AI-native and 3D imaging development and is expected to close in H2 2026, subject to customary regulatory approvals.

Loading...
Loading translation...

Positive

  • 1,500 employees contributed to the joint venture
  • $625 million projected 2026 revenue moved to JV
  • Focus on accelerating AI-native and 3D imaging screening solutions
  • Privately held, U.S.-based structure with global operational reach

Negative

  • Transaction subject to regulatory approvals, risking closing delays
  • Leidos transfers $625M projected revenue to JV, reducing standalone SES revenue exposure
  • Integration and execution of combined R&D and manufacturing may challenge timelines

News Market Reaction – LDOS

+1.84%
1 alert
+1.84% News Effect

On the day this news was published, LDOS gained 1.84%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Employees contributed: 1,500 employees Projected revenue: $625 million Expected closing: Second half of 2026 +1 more
4 metrics
Employees contributed 1,500 employees Leidos staff moving into new joint venture
Projected revenue $625 million Projected 2026 revenue contributed to joint venture
Expected closing Second half of 2026 Targeted closing timeline for the transaction
Strategy horizon 2030 Referenced in Leidos NorthStar 2030 strategy

Market Reality Check

Price: $158.95 Vol: Volume 853,899 is below t...
normal vol
$158.95 Last Close
Volume Volume 853,899 is below the 20-day average of 1,053,851, suggesting subdued trading ahead of the JV news. normal
Technical Price $156.17 is trading below the 200-day MA of $179.73, reflecting a weaker intermediate trend pre-announcement.

Peers on Argus

LDOS was down 0.9% while momentum peers CTSH and WIT were up 3.07% and 2.39%, re...
2 Up

LDOS was down 0.9% while momentum peers CTSH and WIT were up 3.07% and 2.39%, respectively, indicating stock-specific drivers rather than a sector-wide move.

Previous Partnership Reports

2 past events · Latest: Sep 24 (Positive)
Same Type Pattern 2 events
Date Event Sentiment Move Catalyst
Sep 24 Strategic joint venture Positive +0.1% Purple Sky JV with Sky Solutions to accelerate federal health digital transformation.
Aug 07 Strategic partnership Positive +0.5% Partnership with Second Front Systems to operate Game Warden for secure software delivery.
Pattern Detected

Partnership and joint venture announcements have historically led to modestly positive, aligned price reactions for LDOS.

Recent Company History

Recent partnership activity shows Leidos using joint ventures to extend capabilities in federal and security-focused markets. In August 2025, it partnered with Second Front Systems to operate the Game Warden DevSecOps platform, and in September 2025 it formed the Purple Sky joint venture with Sky Solutions to support federal health digital transformation. Both events saw small positive price moves, framing today’s security screening JV as a continuation of this collaboration strategy.

Historical Comparison

+0.3% avg move · Past partnership announcements produced average moves of about 0.3%, suggesting historically modest ...
partnership
+0.3%
Average Historical Move partnership

Past partnership announcements produced average moves of about 0.3%, suggesting historically modest but positive market reactions to similar collaboration news.

Leidos has steadily expanded via strategic partnerships and joint ventures, enhancing secure software delivery and federal digital services, now extending into security detection and imaging.

Regulatory & Risk Context

Active S-3 Shelf
Shelf Active
Active S-3 Shelf Registration 2026-02-19

Leidos has an effective Form S-3ASR shelf registration dated February 19, 2026, covering multiple security types for general corporate purposes, with at least 2 related prospectus supplements filed shortly after effectiveness.

Market Pulse Summary

This announcement outlines a security-focused joint venture in which Leidos contributes about 1,500 ...
Analysis

This announcement outlines a security-focused joint venture in which Leidos contributes about 1,500 employees and $625 million in projected 2026 revenue, aligning with its NorthStar 2030 strategy. Historically, partnerships have led to modestly positive price moves. Key factors to watch include regulatory approvals, integration efficiency, and how the venture’s AI-native and 3D imaging roadmap compares to prior collaborations. The existing effective shelf registration also frames potential future capital structure decisions.

Key Terms

joint venture, ai-native, 3d imaging, regulatory approvals
4 terms
joint venture financial
"Leidos ... and investment firm Altaris have entered into a joint venture agreement"
A joint venture is when two or more companies team up to work on a specific project or business idea, sharing both the risks and the rewards. It’s like friends starting a lemonade stand together—each contributes resources and they split the profits, making it easier to succeed than going alone.
ai-native technical
"support a faster transition to AI-native and 3D imaging solutions"
A company or product described as ai-native is built from the ground up around artificial intelligence rather than having AI added on later; its core processes, user experience and decision-making rely on machine learning models and data pipelines. Like a house designed for wheelchair access versus one retrofitted, ai-native firms can move faster, scale more cheaply and offer unique products or cost advantages—information investors use to judge future growth potential and risk exposure to model, data or regulatory failures.
3d imaging technical
"support a faster transition to AI-native and 3D imaging solutions"
Three-dimensional imaging is a set of medical technologies that create a lifelike, volumetric view of organs or structures inside the body instead of a flat picture, like turning a paper map into a small model you can rotate. Investors care because these systems often command higher prices, open new markets for devices and software, and can change clinical adoption, regulatory review and reimbursement — all of which affect revenue and growth potential.
regulatory approvals regulatory
"subject to customary closing conditions, including receipt of regulatory approvals"
Regulatory approvals are official permissions from government agencies that a company needs before launching a new product, service, or business activity. They matter because without this approval, the company might not be allowed to operate legally or sell its products, similar to how a driver needs a license to legally drive a car.

AI-generated analysis. Not financial advice.

The new joint venture brings together advanced security detection systems and imaging technology to strengthen airports, borders and critical infrastructure worldwide.

RESTON, Va., April 15, 2026 /PRNewswire/ -- Leidos (NYSE: LDOS) and investment firm Altaris have entered into a joint venture agreement focused on protecting people and places, ensuring the free flow of commerce and travelers and strengthening national and global security. The partnership will enhance security screening by promoting innovation, delivering more efficient solutions and strengthening security screening for airports, borders and critical infrastructure customers worldwide.

This joint venture combines Leidos' Security Enterprise Solutions (SES) business and Altaris-owned Analogic, bringing together complementary detection technologies, manufacturing capabilities and engineering expertise into a single, U.S.-based enterprise with global operational reach.

Consolidating these two businesses aims to improve security product innovation while unlocking efficiencies in research and development, manufacturing and operations of next-generation screening technologies. It also aims to support a faster transition to AI-native and 3D imaging solutions, helping advance more efficient and effective screening capabilities.

"Our unified joint venture represents a focused step to strengthen U.S. capabilities in security detection at a time when global travel and trade continue to grow," said Leidos Chief Executive Officer Tom Bell. "Combining SES with Analogic will position the new company to promote investment in innovation, deliver more efficient solutions for the U.S. government and ensure that the world's advanced security technology is designed and engineered from the United States."

"Today marks an important milestone for our company and for the security industry. By combining two highly complementary organizations, we are creating a stronger, more capable company with the expertise and breadth of solutions to better meet evolving customer needs worldwide," said Analogic Chief Executive Officer Tom Ripp.

The proposed deal will allow the new company to focus on growth in the global detection and imaging market and for Leidos to continue investing in core growth areas identified in its NorthStar 2030 strategy.

Transaction Details

As part of the deal, Leidos will contribute approximately 1,500 employees representing $625 million in projected 2026 revenue to the new joint venture. The privately held company will operate under the Analogic brand, with Leidos retaining significant minority ownership.

Approvals and Timing

The transaction is expected to close in the second half of 2026, subject to customary closing conditions, including receipt of regulatory approvals.

Advisors

Leidos retained PJT Partners as financial advisor, Fried, Frank, Harris, Shriver & Jacobson LLP and DLA Piper as legal advisors and KPMG as accounting advisor in connection with the transaction. Kirkland & Ellis LLP and Hinckley Allen & Snyder LLP acted as legal advisors to Analogic, along with Ernst & Young LLP as accounting advisor.

About Leidos        

Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Headquartered in Reston, Virginia, with approximately 50,000 global employees, Leidos reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026. For more information, visit www.leidos.com.  

About Analogic

Analogic, headquartered in Salem, NH, is a global leader in design, development, manufacturing and support of technically advanced and cost-effective imaging & detection and power technology solutions for aviation security, healthcare and other high-end industrial markets. For more information, visit www.analogic.com.

About Altaris

Altaris is an investment firm with an exclusive focus on acquiring and building companies in the healthcare industry. Since its inception in 2003, Altaris has invested in more than 50 companies across a range of healthcare subsectors, with a consistent goal of delivering value to the healthcare system and generating attractive financial returns for investors. Altaris is headquartered in New York City and manages $9+ billion of equity capital. For more information, visit www.altariscap.com.

Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including, but not limited to: our ability to complete this transaction at all or in accordance with any anticipated timeline; our ability to achieve the satisfaction or waiver of all conditions to the closing of this transaction, including receipt of required regulatory approvals; the ability of the new joint venture company to successfully integrate the SES business and Analogic at all or otherwise in accordance with any anticipated timeline;  developments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, future delays in the U.S. government budget process, or the U.S. government's failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession; uncertainties in tax due to new tax legislation or other regulatory developments; deterioration of economic conditions or weakening in credit or capital markets; uncertainty in the consequences of current and future geopolitical events; inflationary pressures and fluctuations in interest rates; delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our company; our ability to effectively compete and win contracts with the U.S. government and other customers; our ability to respond rapidly to emerging technology trends, including the use of artificial intelligence; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by U.S. government and commercial organizations in environmental impact and remediation projects; the effects of an epidemic, pandemic or similar outbreak may have on our business, financial position, results of operations and/or cash flows; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; our ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price contracts and other contracts; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; cybersecurity, data security or other security threats, system failures or other disruptions of our business; our compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer, disposal and other processing, technology protection and personal information; the damage and disruption to our business resulting from natural disasters and the effects of climate change; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks; our ability to manage risks associated with our international business; our ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations; our ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements; our ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; our ability to successfully integrate acquired businesses; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks described in our Securities and Exchange Commission filings.

Media Contact
Victor Melara
Senior Media Relations Manager
703.431.4612
victor.a.melara@leidos.com

Investor Relations
Stuart Davis
571.526.6124
ir@leidos.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/leidos-security-enterprise-solutions-and-analogic-partner-to-form-american-joint-venture-and-strengthen-global-security-screening-capabilities-302742575.html

SOURCE Leidos

FAQ

What are the key terms of the Leidos (LDOS) joint venture with Analogic announced April 15, 2026?

The JV combines Leidos SES and Analogic into a privately held Analogic-branded company. According to the company, Leidos will contribute about 1,500 employees and $625 million of projected 2026 revenue, with Leidos retaining a significant minority stake.

When is the Leidos and Analogic joint venture (LDOS) expected to close and what conditions apply?

The transaction is expected to close in the second half of 2026, subject to customary conditions. According to the company, closing depends on receipt of required regulatory approvals and other standard closing conditions.

How much revenue and headcount is Leidos (LDOS) contributing to the new joint venture?

Leidos will contribute approximately 1,500 employees and $625 million in projected 2026 revenue. According to the company, these contributions form the operational base of the privately held Analogic-branded enterprise.

What strategic benefits does the Leidos-Analogic JV aim to deliver for LDOS shareholders?

The JV aims to accelerate innovation and operational efficiencies in detection and imaging technologies. According to the company, combining capabilities should speed AI-native and 3D imaging adoption and improve R&D and manufacturing efficiency.

Will Leidos (LDOS) retain ownership or control after forming the Analogic joint venture?

Leidos will retain a significant minority ownership stake in the new company. According to the company, the privately held entity will operate under the Analogic brand while Leidos remains a meaningful investor.

What are the main investor risks from the LDOS and Analogic joint venture announced April 15, 2026?

Primary risks include regulatory approval delays and integration execution challenges. According to the company, the deal is subject to customary regulatory approvals and closing conditions that could affect timing and outcomes.